Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Drug and molecular radiotherapy combinations for metastatic castration resistant prostate cancer

Published:2021-05 Issue: Volume:96-97 Page:101-111
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Staniszewska Magdalena,Iking Janette,Lückerath Katharina,Hadaschik Boris,Herrmann Ken,Ferdinandus Justin,Fendler Wolfgang P.

Funder

Doktor Robert Pfleger Foundation Bamberg

Mercator Foundation

German Research Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference154 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018

2. Androgen action and metabolism in prostate cancer;Green;Mol Cell Endocrinol,2012

3. Role of androgen receptor in prostate cancer: a review;Fujita;The world journal of men’s health,2019

4. Treatment of advanced prostate cancer-a review of current therapies and future promise;Sumanasuriya;Cold Spring Harb Perspect Med,2018

5. Drug discovery in advanced prostate cancer: translating biology into therapy;Yap;Nat Rev Drug Discov,2016

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LC-MS/MS method for dual-ligand peptide-drug CBP-1018 and its deconjugated payload MMAE including sample stabilization strategy for its MC-Val-Cit-PABC linker;Talanta;2024-11

2. Assessment of structural and activity-related contributions of various PIM-1 kinase inhibitors in the treatment of leukemia and prostate cancer;Molecular Diversity;2024-04-20

3. Synergistic Activity of DNA Damage Response Inhibitors in Combination with Radium-223 in Prostate Cancer;Cancers;2024-04-15

4. Advances in prostate cancer treatment: Radionuclide therapy for prostate cancer;Advances in Cancer Research;2024

5. Effect of ubiquitin protease system on DNA damage response in prostate cancer (Review);Experimental and Therapeutic Medicine;2023-11-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3